Showing results (11-20 of 171) with videos related to
Sort By:
Pageof 18
The American Journal of Cardiology|October 16, 1987
Ethmozine (moricizine HCl) therapy for complex ventricular arrhythmiasM J Hession, S Lampert, P J Podrid, et al.Circulation|August 1, 1984
Safety of maximal exercise testing in patients at high risk for ventricular arrhythmiaD Z Young, S Lampert, T B Graboys, et al.The American Journal of Cardiology|March 15, 1990
Assessment of the hemodynamic response to acetyl-strophanthidin by Doppler echocardiography in normal subjects and in those with coronary artery disease or idiopathic dilated cardiomyopathyH W Lange, S Lampert, M G Sutton, et al.American Heart Journal|May 1, 1984
Long-term mexiletine for ventricular arrhythmiaJ Stein, P J Podrid, S Lampert, et al.American Heart Journal|October 1, 1992
The prevalence of proarrhythmic events during moricizine therapy and their relationship to ventricular functionO Tschaidse, T B Graboys, B Lown, et al.American Heart Journal|May 1, 1986
The role of beta blocking agents as adjunct therapy to membrane stabilizing drugs in malignant ventricular arrhythmiaG Hirsowitz, P J Podrid, S Lampert, et al.JAMA|November 11, 1992
Results of a second-opinion trial among patients recommended for coronary angiographyT B Graboys, B Biegelsen, S Lampert, et al.The American Journal of Cardiology|October 16, 1987
Considerations of current methods for drug selection in treating malignant ventricular arrhythmiasB Lown, P J Podrid, T B Graboys, et al.JAMA|September 25, 1987
Results of a second-opinion program for coronary artery bypass graft surgeryT B Graboys, A Headley, B Lown, et al.Journal of the American College of Cardiology|February 1, 1986
Mexiletine and tocainide: does response to one predict response to the other?M Hession, R Blum, P J Podrid, et al.Pageof 18